Suppr超能文献

相似文献

1
Distinct patterns of kidney and liver cyst growth in pkd2(WS25/-) mice.
Nephrol Dial Transplant. 2010 Nov;25(11):3496-504. doi: 10.1093/ndt/gfq195. Epub 2010 Apr 13.
2
VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
Am J Physiol Cell Physiol. 2007 Jul;293(1):C419-28. doi: 10.1152/ajpcell.00038.2007. Epub 2007 May 2.
3
Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.
Gastroenterology. 2012 Mar;142(3):622-633.e4. doi: 10.1053/j.gastro.2011.11.036. Epub 2011 Dec 7.
5
Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
Nephrol Dial Transplant. 2006 Aug;21(8):2078-84. doi: 10.1093/ndt/gfl150. Epub 2006 May 23.
6
CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.
Am J Physiol Cell Physiol. 2008 Mar;294(3):C786-96. doi: 10.1152/ajpcell.00457.2007. Epub 2008 Jan 16.
7
Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
J Biol Chem. 2009 Mar 13;284(11):7214-22. doi: 10.1074/jbc.M805890200. Epub 2008 Dec 20.
8
Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
J Hepatol. 2017 Mar;66(3):571-580. doi: 10.1016/j.jhep.2016.10.032. Epub 2016 Nov 5.

引用本文的文献

3
Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance.
Cell. 2015 May 7;161(4):737-49. doi: 10.1016/j.cell.2015.03.031.
4
Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.
Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F349-57. doi: 10.1152/ajprenal.00478.2014. Epub 2014 Dec 23.
5
An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.
Hum Mol Genet. 2014 Sep 15;23(18):4919-31. doi: 10.1093/hmg/ddu208. Epub 2014 May 8.
6
Nanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imaging.
Adv Chronic Kidney Dis. 2013 Nov;20(6):488-99. doi: 10.1053/j.ackd.2013.06.001.
7
Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD).
Am J Physiol Renal Physiol. 2011 May;300(5):F1235-43. doi: 10.1152/ajprenal.00348.2010. Epub 2011 Jan 26.

本文引用的文献

1
Oncologic imaging end-points for the assessment of therapy response.
Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):36-53. doi: 10.2174/157489209787002434.
2
Unified ultrasonographic diagnostic criteria for polycystic kidney disease.
J Am Soc Nephrol. 2009 Jan;20(1):6-8. doi: 10.1681/ASN.2008111164. Epub 2008 Dec 10.
3
Functional MRI: evaluation of chronic kidney disease with perfusion imaging.
Acad Radiol. 2009 Jan;16(1):88-95. doi: 10.1016/j.acra.2008.07.002.
4
Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months.
Kidney Int. 2009 Jan;75(2):235-41. doi: 10.1038/ki.2008.558. Epub 2008 Oct 29.
5
Polycystic kidney disease.
Annu Rev Med. 2009;60:321-37. doi: 10.1146/annurev.med.60.101707.125712.
6
Clinical practice. Autosomal dominant polycystic kidney disease.
N Engl J Med. 2008 Oct 2;359(14):1477-85. doi: 10.1056/NEJMcp0804458.
7
MRI of pelvic floor dysfunction: dynamic true fast imaging with steady-state precession versus HASTE.
AJR Am J Roentgenol. 2008 Aug;191(2):352-8. doi: 10.2214/AJR.07.3403.
8
Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury.
Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L152-61. doi: 10.1152/ajplung.00515.2007. Epub 2008 Apr 25.
9
Tracking kidney volume in mice with polycystic kidney disease by magnetic resonance imaging.
Kidney Int. 2008 Mar;73(6):778-81. doi: 10.1038/sj.ki.5002771. Epub 2008 Jan 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验